Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)

Price$0.41

Value ScoreA

Growth ScoreA

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-67.90%

Price vs S&P 500 (4W)-27.38%

VGM Score65.80

Market Capitalization$1.52M

P/E Ratio (Annual)0.41x

All Metrics

Book Value / Share (Quarterly)$0.00

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.00

Price vs S&P 500 (YTD)-50.26%

Gross Margin (TTM)-188.20%

Net Profit Margin (TTM)-596.98%

EPS (TTM)$-0.00

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$-0.00

EPS (Annual)$-0.00

ROI (Annual)-98.93%

Gross Margin (Annual)-202.29%

Cash / Share (Quarterly)$0.00

P/E Basic Excl Extra (TTM)0.48x

Revenue Growth QoQ (YoY)536.41%

P/E Normalized (Annual)0.41x

ROA (Last FY)-71.45%

Revenue Growth TTM (YoY)216.72%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-62.91%

Operating Margin (TTM)-542.47%

Cash Flow / Share (Annual)$-0.00

P/B Ratio0.19x

P/B Ratio (Quarterly)0.08x

Net Income / Employee (Annual)$-184,600

EV / Revenue (TTM)0.07x

Net Interest Coverage (TTM)-9.86x

ROA (TTM)-106.03%

EV / EBITDA (TTM)0.02x

EPS Incl Extra (Annual)$-0.00

Current Ratio (Annual)1.30x

Quick Ratio (Quarterly)1.19x

3-Month Avg Trading Volume2.38M

52-Week Price Return-87.31%

P/E Incl Extra (TTM)0.48x

Revenue / Employee (TTM)$46,300

Tangible BV / Share (Quarterly)$-1.96

P/S Ratio (Annual)1.16x

Asset Turnover (Annual)0.11x

52-Week High$6.18

EPS Excl Extra (Annual)$-0.00

CapEx CAGR (5Y)-57.75%

26-Week Price Return-59.97%

Quick Ratio (Annual)1.25x

13-Week Price Return-49.29%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)1.30x

Enterprise Value$155,600

Asset Turnover (TTM)0.18x

Revenue / Employee (Annual)$29,100

Pretax Margin (Annual)-633.64%

Cash / Share (Annual)$0.00

3-Month Return Std Dev158.33%

Net Income / Employee (TTM)$-276,500

ROE (Last FY)-102.52%

Net Interest Coverage (Annual)-9.95x

EPS Basic Excl Extra (Annual)$-0.00

Receivables Turnover (TTM)26.72x

Total Debt / Equity (Quarterly)0.04x

EPS Incl Extra (TTM)$-0.00

ROI (TTM)-150.36%

P/S Ratio (TTM)0.73x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$-0.71

Price vs S&P 500 (52W)-111.68%

P/E Ratio (TTM)0.48x

Year-to-Date Return-42.10%

5-Day Price Return-17.54%

EPS Normalized (Annual)$-0.00

ROA (5Y Avg)-26.60%

Net Profit Margin (Annual)-633.64%

Month-to-Date Return-8.38%

EBITD / Share (Annual)$-0.00

Operating Margin (Annual)-575.29%

LT Debt / Equity (Annual)0.04x

ROI (5Y Avg)-37.83%

P/E Excl Extra (TTM)0.48x

LT Debt / Equity (Quarterly)0.04x

EPS Basic Excl Extra (TTM)$-0.00

P/B Ratio (Annual)0.08x

Pretax Margin (TTM)-596.98%

Book Value / Share (Annual)$0.00

Price vs S&P 500 (13W)-57.54%

Beta2.08x

Revenue / Share (TTM)$0.00

ROE (TTM)-155.89%

52-Week Low$0.37

vGradeA

gGradeA

mGradeF

vgmGradeB

Show chart for

Analyst Recommendations

May 2024

Jun 2024

Jul 2024

Aug 2024

4.14

Industry Peers — Biological Products(178)

Symbol	Value Score	Growth Score	Momentum Score	Price
SCNIScinai Immunotherapeutics Ltd. American Depositary Shares	A	A	F	$0.41
AMGNAmgen Inc	C	C	C	$349.58
GILDGilead Sciences Inc	C	B	C	$129.16
ARGXargenx SE American Depositary Shares	D	A	B	$891.32
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$149.23
BIIBBiogen Inc. Common Stock	B	D	B	$195.34
BNTXBioNTech SE American Depositary Share	C	C	D	$88.08
MRNAModerna, Inc. Common Stock	C	B	B	$47.44
NBIXNeurocrine Biosciences Inc	C	B	B	$163.88
EXELExelixis Inc	C	B	B	$52.70
KRYSKrystal Biotech, Inc. Common Stock	D	B	A	$301.00

About

Scinai Immunotherapeutics operates a diversified biopharmaceutical model combining contract manufacturing services with proprietary drug development. The company's CDMO division provides drug development and GMP manufacturing support to biotech clients, representing the majority of current revenue. In-house, it is developing NanoAbs—nanosized VHH antibodies—targeting inflammation and immunology conditions with significant unmet medical needs.